Cervical cancer screening in pregnancy US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Cervical cancer screening in pregnancy. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Cervical cancer screening in pregnancy US Medical PG Question 1: A 56-year-old woman makes an appointment with her physician to discuss the results of her cervical cancer screening. She has been menopausal for 2 years and does not take hormone replacement therapy. Her previous Pap smear showed low-grade squamous intraepithelial lesion (LSIL); no HPV testing was performed. Her gynecologic examination is unremarkable. The results of her current Pap smear is as follows:
Specimen adequacy satisfactory for evaluation
Interpretation low-grade squamous intraepithelial lesion
Notes atrophic pattern
Which option is the next best step in the management of this patient?
- A. Reflex HPV testing
- B. Colposcopy (Correct Answer)
- C. Repeat HPV testing in 6 months
- D. Immediate loop excision
- E. Intravaginal estrogen therapy followed by repeat Pap smear in 1 week
Cervical cancer screening in pregnancy Explanation: **Colposcopy**
- For postmenopausal women with **LSIL**, current guidelines recommend immediate colposcopy due to the slightly increased risk of underlying **high-grade cervical intraepithelial neoplasia (CIN2+)** compared to premenopausal women.
- The "atrophic pattern" note suggests potential for difficulty in cytology interpretation, making direct visualization and biopsy with colposcopy more appropriate for thorough evaluation.
*Reflex HPV testing*
- While HPV testing is often used with LSIL, in a postmenopausal woman with a persistent LSIL result, immediate colposcopy is preferred over reflex HPV testing due to a higher likelihood of significant pathology and the potential for **false negatives in HPV testing** in this age group.
- The patient already has a history of LSIL, and reflex HPV testing might delay definitive diagnosis or treatment for potential underlying high-grade lesions.
*Intravaginal estrogen therapy followed by repeat Pap smear in 1 week*
- While the Pap smear shows an **atrophic pattern** and estrogen therapy can improve cellular maturation making cytology interpretation easier, this approach is not recommended as the initial management for persistent LSIL in a postmenopausal woman.
- The patient already has a **second LSIL result**, indicating this is not simply atrophic changes causing interpretation difficulty, and colposcopy is warranted regardless of the atrophic pattern.
*Repeat HPV testing in 6 months*
- Repeat HPV testing in 6 months might be considered in younger, premenopausal women with LSIL, but in a 56-year-old postmenopausal woman with a history of LSIL, this approach would delay necessary investigation for potential high-grade lesions.
- The risk profile for CIN2+ is different in postmenopausal women, warranting a more aggressive management approach.
*Immediate loop excision*
- **Loop electrosurgical excision procedure (LEEP)** is a therapeutic procedure used to remove high-grade lesions (CIN2, CIN3), not usually indicated as the immediate next step for LSIL.
- A colposcopy with directed biopsies is required first to confirm the presence and grade of any underlying lesion before considering an excisional procedure.
Cervical cancer screening in pregnancy US Medical PG Question 2: A 29-year-old G1P0 presents to her obstetrician for her first prenatal care visit at 12 weeks gestation by last menstrual period. She states that her breasts are very tender and swollen, and her exercise endurance has declined. She otherwise feels well. She is concerned about preterm birth, as she heard that certain cervical procedures increase the risk. The patient has a gynecologic history of loop electrosurgical excision procedure (LEEP) for cervical dysplasia several years ago and has had negative Pap smears since then. She also has mild intermittent asthma that is well controlled with occasional use of her albuterol inhaler. At this visit, this patient’s temperature is 98.6°F (37.0°C), pulse is 69/min, blood pressure is 119/61 mmHg, and respirations are 13/min. Cardiopulmonary exam is unremarkable, and the uterine fundus is just palpable at the pelvic brim. Pelvic exam reveals normal female external genitalia, a closed and slightly soft cervix, a 12-week-size uterus, and no adnexal masses. Which of the following is the best method for evaluating for possible cervical incompetence in this patient?
- A. Transabdominal ultrasound in the first trimester
- B. Transvaginal ultrasound in the first trimester
- C. Serial transvaginal ultrasounds starting at 16 weeks gestation
- D. Transabdominal ultrasound at 18 weeks gestation
- E. Transvaginal ultrasound at 18 weeks gestation (Correct Answer)
Cervical cancer screening in pregnancy Explanation: ***Transvaginal ultrasound at 18 weeks gestation***
- A history of **LEEP** is a risk factor for **cervical incompetence** and warrants screening with transvaginal ultrasound.
- The optimal timing for **cervical length** screening in women with a history of cervical procedures is typically between **18 and 24 weeks gestation**, as the risk of cervical shortening usually manifests during this period.
*Transabdominal ultrasound in the first trimester*
- **Transabdominal ultrasound** is generally not ideal for precise **cervical length measurement** due to potential shadowing from the fetus or maternal obesity.
- **First-trimester cervical length measurement** is not typically recommended for routine screening of cervical incompetence, as changes are less pronounced early in pregnancy.
*Transvaginal ultrasound in the first trimester*
- While more accurate than transabdominal, **first-trimester transvaginal ultrasound** for cervical length is not standard for predicting cervical incompetence.
- Significant cervical shortening due to incompetence often occurs later in the second trimester, so early screening may miss the condition.
*Serial transvaginal ultrasounds starting at 16 weeks gestation*
- While **serial transvaginal ultrasounds** starting at 16 weeks can be part of a management plan for high-risk patients, the most critical single assessment typically occurs at **18-24 weeks**.
- Starting serial scans too early may not be necessary if the cervix is long and closed at the initial key screening, unless there are other strong indications.
*Transabdominal ultrasound at 18 weeks gestation*
- Similar to first-trimester transabdominal ultrasound, **transabdominal imaging** at 18 weeks is generally **less accurate** than transvaginal for measuring cervical length.
- **Transvaginal ultrasound** offers a clearer and more precise view of the cervix, which is crucial for assessing potential shortening or funneling.
Cervical cancer screening in pregnancy US Medical PG Question 3: A 39-year-old woman presents to her gynecologist for a routine visit. She has no complaints during this visit. She had an abnormal pap test 6 years ago that showed atypical squamous cells of undetermined significance. The sample was negative for human papillomavirus. On her follow-up Pap test 3 years later, there was no abnormality. The latest pap test results show atypical glandular cells with reactive changes in the cervical epithelium. The gynecologist decides to perform a colposcopy, and some changes are noted in this study of the cervical epithelium. The biopsy shows dysplastic changes in the epithelial cells. Which of the following is the next best step in the management of this patient?
- A. Follow-up pap smear in one year
- B. Follow-up pap smear in 3 years
- C. Cold knife conization (Correct Answer)
- D. Repeat colposcopy in 6 months
- E. Loop electrosurgical excision procedure
Cervical cancer screening in pregnancy Explanation: ***Cold knife conization***
- This patient presents with **atypical glandular cells** and **dysplastic changes** on biopsy, which can indicate **adenocarcinoma in situ** or **invasive adenocarcinoma**. **Cold knife conization** allows for a complete excision of the transformation zone, including the endocervical canal, which is essential for accurate diagnosis and treatment of glandular lesions.
- This procedure provides a high-quality, intact specimen for thorough histopathological examination, enabling the pathologist to determine the extent and depth of the lesion, which guides further management.
*Follow-up pap smear in one year*
- This option is inappropriate given the presence of **dysplastic changes** on biopsy following atypical glandular cells; these findings indicate a high risk that requires immediate definitive action, not merely observation.
- Delaying further diagnostic or therapeutic interventions for a year could allow a potentially significant lesion, especially a glandular one, to progress.
*Follow-up pap smear in 3 years*
- This is not an appropriate next step due to the finding of **atypical glandular cells** and **dysplastic changes** on biopsy, which necessitate prompt and comprehensive evaluation and management.
- Longer follow-up intervals are reserved for women with normal screens and no high-risk findings, not for those with confirmed dysplasia.
*Repeat colposcopy in 6 months*
- A repeat colposcopy without excisional biopsy would be insufficient because the **dysplastic changes** on biopsy already confirm the presence of a lesion that requires definitive management.
- **Atypical glandular cells** and dysplasia frequently originate higher in the endocervical canal, beyond the view of colposcopy, necessitating an excisional procedure like conization for complete evaluation.
*Loop electrosurgical excision procedure*
- A **LEEP** might be considered for squamous lesions, but for **atypical glandular cells** and suspected glandular dysplasia, **cold knife conization** is generally preferred.
- While LEEP can be used, it may not provide as clear or deep margins as cold knife conization, potentially leading to incomplete excision or difficulty in histological assessment, especially if the lesion extends high into the endocervical canal.
Cervical cancer screening in pregnancy US Medical PG Question 4: A 38-year-old G2P2 presents to her gynecologist to discuss the results of her diagnostic tests. She has no current complaints or concurrent diseases. She underwent a tubal ligation after her last pregnancy. Her last Pap smear showed a high-grade squamous intraepithelial lesion and a reflex HPV test was positive. Colposcopic examination reveals areas of thin acetowhite epithelium with diffuse borders and fine punctation. The biopsy obtained from the suspicious areas shows CIN 1. Note the discordancy between the cytology (HSIL) and histology (CIN 1) results. Which of the following is an appropriate next step in the management of this patient?
- A. Test for type 16 and 18 HPV
- B. Cryoablation
- C. Cold-knife conization
- D. Loop electrosurgical excision procedure
- E. Repeat cytology and HPV co-testing in 6 months (Correct Answer)
Cervical cancer screening in pregnancy Explanation: ***Repeat cytology and HPV co-testing in 6 months***
- In cases of **discordant results** where cytology shows **HSIL** but histology only shows **CIN 1**, repeat co-testing in 6 months is an appropriate management strategy, especially if the **colposcopy was satisfactory** (entire squamocolumnar junction visualized). This approach allows for monitoring while avoiding overtreatment, as many low-grade lesions spontaneously regress.
- Given the patient's history (G2P2, tubal ligation), future fertility is not a concern, making conservative management suitable when there's uncertainty about the severity of the lesion.
*Test for type 16 and 18 HPV*
- The patient already has a **positive reflex HPV test**, indicating the presence of high-risk HPV. Knowing the specific types (16 or 18) would assist in risk stratification, but it would not change the immediate management given the existing discordance between HSIL cytology and CIN 1 histology.
- While **HPV 16 and 18** are associated with a higher risk of progression to cancer, current guidelines for discordant HSIL/CIN 1 emphasize observation or excisional procedures based on other factors, not just specific HPV typing if HPV is already confirmed as positive.
*Cryoablation*
- **Cryoablation** is an ablative treatment that destroys abnormal cervical tissue. It is typically reserved for confirmed **CIN 2 or CIN 3** with a satisfactory colposcopy, when there is no suspicion of invasive cancer.
- Applying an ablative treatment like cryoablation based on discordant results (HSIL with CIN 1) without further clarification could lead to overtreatment, and it may not fully address the possibility of a missed higher-grade lesion elsewhere.
*Cold-knife conization*
- **Cold-knife conization** is an excisional procedure used to remove a cone-shaped piece of cervical tissue, typically for confirmed **CIN 2 or CIN 3**, or when **colposcopy is unsatisfactory**, or there's a suspicion of invasive disease, or glandular lesions.
- Performing a conization based on HSIL cytology but only CIN 1 histology, without further investigation or follow-up, is premature and unnecessarily aggressive given the potential for an overestimation of disease severity by cytology alone.
*Loop electrosurgical excision procedure*
- **LEEP** is an excisional procedure commonly used for the management of **high-grade cervical intraepithelial neoplasia (CIN 2 or CIN 3)** or when there is a significant discrepancy between cytology and histology that suggests a higher-grade lesion.
- While LEEP is an excisional procedure, it is typically performed when there is a confirmed CIN 2/3, not when histology shows CIN 1, especially given the potential for spontaneous regression and the less invasive options for managing discordant results.
Cervical cancer screening in pregnancy US Medical PG Question 5: A 31-year-old female presents to her gynecologist for a routine Pap smear. Her last Pap smear was three years ago and was normal. On the current Pap smear, she is found to have atypical squamous cells of unknown significance (ASCUS). Reflex HPV testing is positive. What is the best next step?
- A. Colposcopy (Correct Answer)
- B. Repeat Pap smear and HPV testing in 5 years
- C. Repeat Pap smear in 3 years
- D. Repeat Pap smear in 1 year
- E. Loop electrosurgical excision procedure (LEEP)
Cervical cancer screening in pregnancy Explanation: ***Colposcopy***
- A **colposcopy** is indicated for a patient over 25 with **atypical squamous cells of undetermined significance (ASCUS)** and a **positive high-risk human papillomavirus (HPV) test** to evaluate for cervical intraepithelial neoplasia (CIN).
- The positive HPV test suggests a higher risk of underlying cervical disease requiring direct visualization and potentially biopsy of abnormal areas.
*Repeat Pap smear and HPV testing in 5 years*
- This option is incorrect because a **positive HPV test** along with ASCUS indicates a need for more immediate and invasive evaluation than routine screening.
- Waiting five years could allow progression of potential **cervical dysplasia** without intervention.
*Repeat Pap smear in 3 years*
- This timeframe is typically for women aged 21-29 with a normal Pap smear and negative HPV, or for follow-up after low-grade abnormalities, not for ASCUS with positive HPV.
- The presence of **high-risk HPV** mandates a more aggressive follow-up strategy.
*Repeat Pap smear in 1 year*
- This might be an option for ASCUS with a **negative HPV test** or for adolescents, but it is insufficient when high-risk HPV is positive.
- A **high-risk HPV infection** following an ASCUS result requires colposcopy to rule out significant cervical lesions.
*Loop electrosurgical excision procedure (LEEP)*
- A **LEEP** is a therapeutic procedure used to remove abnormal cervical tissue, usually performed after a colposcopy and biopsy confirms a high-grade lesion (CIN 2 or 3).
- Performing a LEEP immediately without a preceding colposcopy and biopsy would be **premature** as the diagnosis of the severity of cervical changes is not yet confirmed.
Cervical cancer screening in pregnancy US Medical PG Question 6: A 28-year-old woman comes to the physician because she had a positive pregnancy test at home. She reports feeling nauseated and has vomited several times over the past week. During this period, she has also had increased urinary frequency. She is sexually active with her boyfriend and they use condoms inconsistently. Her last menstrual period was 5 weeks ago. Physical examination shows no abnormalities. A urine pregnancy test is positive. A pap smear is positive for a high-grade squamous intraepithelial lesion. Colposcopy shows cervical intraepithelial neoplasia grade II and III. Which of the following is the most appropriate next step in the management of this patient?
- A. Perform loop electrosurgical excision
- B. Diagnostic excisional procedure
- C. Colposcopy and cytology at 6-month intervals for 12 months
- D. Reevaluation with cytology and colposcopy 6 weeks after birth (Correct Answer)
- E. Endocervical curettage
Cervical cancer screening in pregnancy Explanation: ***Reevaluation with cytology and colposcopy 6 weeks after birth***
- Pregnancy is a state of relative **immunosuppression**, allowing high-grade lesions (CIN II/III) to potentially regress postpartum.
- **Invasive procedures** should be delayed until after delivery to avoid obstetric complications unless invasion is suspected.
*Perform loop electrosurgical excision*
- This procedure, while effective for CIN II/III, is generally **avoided during pregnancy** due to increased risks of hemorrhage, infection, and preterm labor.
- **Observation** is preferred in pregnant patients with CIN II/III, given the possibility of lesion regression postpartum.
*Diagnostic excisional procedure*
- Like LEEP, diagnostic excisional procedures (e.g., **cone biopsy**) carry significant risks during pregnancy, including **miscarriage** and **cervical incompetence**.
- It is usually reserved for cases where **invasive cancer** cannot be excluded by colposcopy and directed biopsies alone.
*Colposcopy and cytology at 6-month intervals for 12 months*
- While follow-up is appropriate, waiting 6 months for the initial follow-up is **too long** given the patient's pregnant status.
- The standard approach is to reevaluate postpartum, as pregnancy-related changes can affect lesion appearance and natural history.
*Endocervical curettage*
- **Endocervical curettage (ECC)** is **contraindicated in pregnancy** as it can disrupt the pregnancy and lead to complications.
- It is performed in non-pregnant patients to evaluate for disease extending into the endocervical canal.
Cervical cancer screening in pregnancy US Medical PG Question 7: A 19-year-old woman presents for a sports physical. She says she feels healthy and has no concerns. Past medical history is significant for depression and seasonal allergies. Current medications are fluoxetine and oral estrogen/progesterone contraceptive pills. Family history is significant for a sister with polycystic ovarian syndrome (PCOS). The patient denies current or past use of alcohol, recreational drugs, or smoking. She reports that she has been on oral birth control pills since age 14 and uses condoms inconsistently. No history of STDs. She is sexually active with her current boyfriend, who was treated for chlamydia 2 years ago. She received and completed the HPV vaccination series starting at age 11. Her vital signs include: temperature 36.8°C (98.2°F), pulse 97/min, respiratory rate 16/min, blood pressure 120/75 mm Hg. Physical examination is unremarkable. Which of the following are the recommended guidelines for cervical cancer screening for this patient at this time?
- A. Cytology (pap smear) and HPV DNA co-testing every 3 years
- B. Cytology (pap smear) every 3 years
- C. Cytology (pap smear) annually
- D. Cytology (pap smear) and HPV DNA co-testing every 5 years
- E. No cervical cancer screening is indicated at this time (Correct Answer)
Cervical cancer screening in pregnancy Explanation: ***No cervical cancer screening is indicated at this time***
- Current guidelines recommend initiating **cervical cancer screening** at age 21, regardless of sexual activity initiation.
- The patient is 19 years old, therefore, screening is not yet indicated per standard recommendations.
*Cytology (pap smear) and HPV DNA co-testing every 3 years*
- This option is incorrect because **co-testing** with cytology and HPV DNA is generally recommended for women aged 30-65 years, not for women under 21.
- While cytology every 3 years is a recommendation for women 21-29, co-testing is not the primary recommendation in this age group, and the patient is below the screening age.
*Cytology (pap smear) every 3 years*
- This screening interval is recommended for women aged 21-29 years, but the patient is currently 19 years old.
- Initiating screening earlier than 21 years is not recommended due to the high incidence of **transient HPV infections** and low risk of cervical cancer in younger individuals.
*Cytology (pap smear) annually*
- **Annual Pap smears** are no longer recommended for routine screening; guidelines have shifted to longer intervals due to the slow progression of cervical cancer and high rates of HPV clearance.
- Even if screening were indicated, annual cytology is not the current recommendation for any age group, especially not for a 19-year-old.
*Cytology (pap smear) and HPV DNA co-testing every 5 years*
- This screening strategy (**co-testing every 5 years**) is recommended for women aged 30-65 years.
- This patient is only 19 years old, making this recommendation inappropriate for her age.
Cervical cancer screening in pregnancy US Medical PG Question 8: The following set of instruments are used for which procedure?
- A. Biopsy
- B. Dilatation and curettage
- C. Pap smear (Correct Answer)
- D. Hysteroscopy
Cervical cancer screening in pregnancy Explanation: ***Pap smear***
- The image displays a complete set of instruments used for a **Pap smear**, including **glass slides** for sample collection, a **cervical brush**, a **spatula** (cytobrush and Ayre spatula), and a **speculum** to visualize the cervix.
- These tools are specifically designed for collecting cervical cells to screen for **cervical cancer** and **precancerous changes**.
*Biopsy*
- A biopsy typically involves specialized instruments like **punch biopsy tools**, **forceps**, or needles to extract tissue samples, which are not depicted here.
- While glass slides might be used for processing biopsy samples, the primary collection tools are absent.
*Dilatation and curettage*
- This procedure requires instruments such as **dilators** to open the cervix and **curetters** to scrape the uterine lining, which are not shown in the image.
- The instruments shown are for surface cell collection, not for uterine cavity procedures.
*Hysteroscopy*
- Hysteroscopy uses a **hysteroscope**—a thin, lighted tube with a camera—to visualize the inside of the uterus.
- The instruments in the image are for external examination and cervical cell collection, not for direct visualization of the uterine cavity.
Cervical cancer screening in pregnancy US Medical PG Question 9: A 28-year-old woman presents to discuss the results of her Pap smear. Her previous Pap smear 1 year ago showed atypical squamous cells of undetermined significance. This year the Pap smear was negative. She had a single pregnancy with a cesarean delivery. Currently, she and her partner do not use contraception because they are planning another pregnancy. She does not have any concurrent diseases and her family history is unremarkable. The patient is concerned about her previous Pap smear finding. She heard from her friend about a vaccine which can protect her against cervical cancer. She has never had such a vaccine and would like to be vaccinated. Which of the following answers regarding the vaccination in this patient is correct?
- A. The patient can receive the vaccine after the pregnancy test is negative.
- B. This vaccination does not produce proper immunity in people who had at least 1 abnormal cytology report, so is unreasonable in this patient.
- C. HPV vaccination is not recommended for women older than 26 years of age.
- D. The patient should receive this vaccination as soon as possible.
- E. The patient should undergo HPV DNA testing; vaccination is indicated if the DNA testing is negative. (Correct Answer)
Cervical cancer screening in pregnancy Explanation: ***The patient should undergo HPV DNA testing; vaccination is indicated if the DNA testing is negative.***
- This patient had an **abnormal Pap smear** in the past, suggesting possible prior HPV exposure or infection. According to CDC guidelines, patients with a history of abnormal Pap smears should undergo **HPV DNA testing** to evaluate for active HPV infection.
- If the HPV DNA test is negative, suggesting no current HPV infection, then **HPV vaccination** can be considered to protect against future infections with other HPV types she may not have been exposed to.
*The patient can receive the vaccine after the pregnancy test is negative.*
- While HPV vaccination is **contraindicated in pregnancy**, the primary concern in this patient is past abnormal cytology, which warrants further investigation regardless of pregnancy status.
- Simply ensuring she is not pregnant before vaccination would overlook the need to assess her previous HPV exposure and potential **ongoing HPV infection**.
*This vaccination does not produce proper immunity in people who had at least 1 abnormal cytology report, so is unreasonable in this patient.*
- This statement is incorrect. While the vaccine is most effective before HPV exposure, it can still provide protection against other **HPV types** not yet encountered, even in individuals with a history of abnormal cytology.
- The vaccine offers **type-specific immunity**, so even if she was infected with one HPV type, she could still benefit from protection against others.
*HPV vaccination is not recommended for women older than 26 years of age.*
- The **HPV vaccine** is FDA-approved for individuals up to **45 years of age**, though routine vaccination is typically recommended through age 26.
- For individuals aged 27-45 who were not previously vaccinated, shared clinical decision-making with their provider can determine if vaccination is beneficial, especially if they have risk factors for new HPV exposures.
*The patient should receive this vaccination as soon as possible.*
- Administering the vaccine "as soon as possible" without an HPV DNA test in a patient with a history of abnormal Pap smears is not the most appropriate first step.
- This approach would not address the potential for **ongoing HPV infection**, which could make the immediate vaccination less effective for her specific situation and could skip important diagnostic steps.
Cervical cancer screening in pregnancy US Medical PG Question 10: A 45-year-old woman presents with a history of cervical erosion and spotting for the past 2 months. What is the next best step?
- A. LBC + HPV (Correct Answer)
- B. Pap smear + HSV
- C. Pap smear + HBV
- D. LBC + HSV
Cervical cancer screening in pregnancy Explanation: ***LBC + HPV***
- Cervical erosion and spotting are concerning for **cervical intraepithelial neoplasia (CIN)** or **cervical cancer**, making **Liquid-Based Cytology (LBC)** the appropriate screening method.
- **Human Papillomavirus (HPV) testing** is crucial as persistent high-risk HPV infection is the primary cause of cervical cancer and helps in risk stratification and management.
*Pap smear + HSV*
- A **routine Pap smear** (conventional cytology) is less sensitive than LBC for detecting abnormal cervical cells and is generally being phased out by LBC.
- **Herpes Simplex Virus (HSV)** causes genital herpes and is not directly associated with cervical cancer, thus testing for it in this context is not the most appropriate immediate next step.
*Pap smear + HBV*
- As mentioned, a **routine Pap smear** is not the preferred method for cervical cancer screening compared to LBC.
- **Hepatitis B Virus (HBV)** causes liver disease and is entirely unrelated to cervical pathology; therefore, testing for it would be irrelevant to the patient's symptoms.
*LBC + HSV*
- While **LBC** is the correct advanced cytology method, adding **HSV testing** is not indicated as HSV does not cause cervical cancer or intraepithelial lesions that present with cervical erosion and spotting.
- Focus should be on identifying potential malignancy or pre-malignant changes with HPV co-testing, not sexually transmitted infections unrelated to cancer risk.
More Cervical cancer screening in pregnancy US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
